NavDx® is an innovative blood test helping physicians personalize care during every phase of
treatment for people with HPV-positive cancers like oropharyngeal (head and neck) or anal cancer


Confirm the HPV genotype and baseline TTMV-HPV DNA level

During Treatment

Assess response to treatment and determine if there is any molecular residual disease post treatment

Optimize the clinical management of HPV+ cancer across the patient care continuum

Routine testing with NavDx to track and monitor changes in blood TTMV offers a more complete picture of a patient's HPV-driven cancer status than simply relying on physical exams and imaging

Learn more about routine testing with NavDx

We’re here to help!

If you have any questions or would like to know more, contact us or see our FAQs

Naveris is committed to ensuring NavDx is accessible for all appropriate patients with HPV-positive cancer by providing support services and financial assistance to those who qualify.

Get the answers to the most common questions regarding TTMV testing with NavDx and related topics.

To connect with NavDx Client Services, please email, or call Client Services directly at (833) 628-3747 with any questions.